| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 134.600 | 155.497 | 159.669 | 161.935 | 12.214 | 11.591 | 10.500 | 15.180 | 19.494 | 18.174 |
| Total Income - EUR | 134.600 | 155.497 | 159.669 | 161.935 | 12.391 | 11.591 | 10.500 | 15.182 | 19.494 | 18.194 |
| Total Expenses - EUR | 133.794 | 154.397 | 163.992 | 159.047 | 11.404 | 5.641 | 9.049 | 15.194 | 17.788 | 15.453 |
| Gross Profit/Loss - EUR | 805 | 1.100 | -4.323 | 2.889 | 987 | 5.950 | 1.451 | -12 | 1.706 | 2.741 |
| Net Profit/Loss - EUR | 644 | 911 | -5.942 | 1.270 | 742 | 5.611 | 1.136 | -444 | 1.447 | 2.324 |
| Employees | 2 | 2 | 2 | 2 | 1 | 0 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Coviral 2009 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 166 | 223 | 220 | 216 | 211 | 907 | 547 | 203 | 203 | 202 |
| Current Assets | 5.508 | 7.081 | 4.915 | 6.903 | 2.099 | 4.187 | 5.726 | 6.137 | 3.966 | 4.109 |
| Inventories | 74 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.238 | 2.909 | 2.941 | 2.379 | 2.050 | 1.213 | 915 | 1.302 | 234 | 476 |
| Cash | 2.196 | 4.172 | 1.974 | 4.524 | 49 | 2.974 | 4.811 | 4.835 | 3.732 | 3.633 |
| Shareholders Funds | 823 | 1.726 | -4.246 | -2.898 | -2.100 | 3.551 | 4.608 | 4.178 | 2.377 | 2.678 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.851 | 5.579 | 9.380 | 10.016 | 4.410 | 1.542 | 1.664 | 2.163 | 1.791 | 1.633 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4617 - 4617" | |||||||||
| CAEN Financial Year |
4617
|
|||||||||
Comments - Coviral 2009 S.r.l.